Log in to save to my catalogue

Circulating Receptor Activator of Nuclear Factor kB Ligand and triglycerides are associated with pro...

Circulating Receptor Activator of Nuclear Factor kB Ligand and triglycerides are associated with pro...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_9d8e2d89a69045d4ba346a7615ce2adc

Circulating Receptor Activator of Nuclear Factor kB Ligand and triglycerides are associated with progression of lower limb arterial calcification in type 2 diabetes: a prospective, observational cohort study

About this item

Full title

Circulating Receptor Activator of Nuclear Factor kB Ligand and triglycerides are associated with progression of lower limb arterial calcification in type 2 diabetes: a prospective, observational cohort study

Publisher

England: BioMed Central Ltd

Journal title

Cardiovascular Diabetology, 2020-09, Vol.19 (1), p.140-9, Article 140

Language

English

Formats

Publication information

Publisher

England: BioMed Central Ltd

More information

Scope and Contents

Contents

Lower limb arterial calcification is a frequent, underestimated but serious complication of diabetes. The DIACART study is a prospective cohort study designed to evaluate the determinants of the progression of lower limb arterial calcification in 198 patients with type 2 diabetes.
Lower limb arterial calcification scores were determined by compu...

Alternative Titles

Full title

Circulating Receptor Activator of Nuclear Factor kB Ligand and triglycerides are associated with progression of lower limb arterial calcification in type 2 diabetes: a prospective, observational cohort study

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_9d8e2d89a69045d4ba346a7615ce2adc

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_9d8e2d89a69045d4ba346a7615ce2adc

Other Identifiers

ISSN

1475-2840

E-ISSN

1475-2840

DOI

10.1186/s12933-020-01122-4

How to access this item